Valereum Plc (AQSE:VLRM) today announced that it has re-applied to the OTC Markets Group for its Ordinary Shares to be cross traded publicly on the OTCQB Market in the United States, subject to the approval of OTC Markets Group and the satisfaction of customary conditions.

A successful Cross-trade on to the OTCQB Market will enable Valereum’s shares to be traded in US dollars through a wide range of US brokers, providing North American investors with easier access. This increased visibility and accessibility is an integral component of Valereum’s broader US capital-markets strategy, which includes the previously announced intention to progress towards a potential listing on either NASDAQ or the New York Stock Exchange.

The application follows the completion of Valereum’s divestment of the majority of its stake in London BTC Company Limited. This strategic divestment removes a regulatory constraint that had previously prevented the Company from qualifying for an OTCQB Cross-trade under the Investment Company Act of 1940. Clearing this barrier facilitates access to a broader set of international capital pools.

The Board views the submission of the OTCQB application as further evidence of the momentum behind Valereum’s strategic repositioning. Alongside the establishment of the Valereum QGP-SP vehicle and the continued advancement of the planned USD $200m Royalty & Streaming financing, the move towards the OTCQB Market reflects the Company’s vision for long-term growth.

The Company intends to update the market as the Cross-trade application progresses and on any material developments related to its US capital-markets strategy.